China’s Sinopharm Says Its Coronavirus Vaccine Is 79% Effective
December 30, 2020
(CNN) – China’s state-owned pharmaceutical giant Sinopharm has announced its coronavirus vaccine is 79.34% effective. Interim analysis of Phase 3 clinical trials show the vaccine is safe and people who received two doses produced high-level antibodies, according to a statement published Wednesday by Beijing Biological Products Institute Co., a Sinopharm subsidiary. The company said it was seeking formal approval from China’s regulators to distribute the vaccine to the public.